FDA sees economic motive for tainted heparin

-Reuters

04/15/2008 - The contamination of Baxter International Inc's recalled blood thinner heparin likely was done for economic reasons, the head of the U.S. Food and Drug Administration said on Tuesday.

"It was apparently, we suspect, done by virtue of economic fraud," FDA Commissioner Andrew von Eschenbach told a Senate hearing. He added, speaking to reporters afterward, that the agency did not have any evidence.

Baxter recalled most of its heparin products in February after reports of allergic reactions and deaths. An FDA investigation uncovered a heparin-like substance in some batches of the drug's active ingredient, which is made in China. Agency officials said last month the substance likely was cheaper to make than real heparin, which is derived from pig intestines.

If you or a loved one have experienced Heparin Sodium Injection side effects you may be entitled to compensation. Contact the Heparin attorneys of Ennis & Ennis today for a free confidential case evaluation. Our on staff nurse and lawyers are standing by to answer any questions you may have regarding Heparin side effects, a possible Heparin class action lawsuit, or any other type of Heparin Sodium Injection litigation.